Superinfected COVID‐19 in a young patient with posterior reversible encephalopathy syndrome: A case report

Abstract

Key Clinical MessagePosterior reversible encephalopathy syndrome (PRES) is a clinical syndrome with central nervous system (CNS) symptoms usually related to autoregulatory cerebral failure and high blood pressure. Neuroimaging is critical to diagnosis. Neurological presentations of COVID‐19 disease are categorized into CNS symptoms and peripheral nervous system (PNS) symptoms. The patient was a 15‐year‐old female with SARS‐CoV‐2 pneumonia who developed PRES with a typical clinical and radiological appearance. She was treated with dexamethasone, phenytoin, sodium valproate and remdesivir. The patient was discharged after recovery of symptoms and was in good general condition. It is recommended that in patients affected by COVID‐19 with neurological symptoms, the PRES can be considered in the differential diagnosis.